Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study

Summary

To explore the hypothesis that the use of Lopinavir/ritonavir will be associated with improved CD4 immune reconstitution in volunteers who fail to demonstrate a significant CD4 cell increase (while on their first antiretroviral treatment regimen) despite sustained viral suppression by a non-Lopinavir/ritonavir-containing regimen

Timeline

Start

2005-12

Primary completion

2009-05

Completion

2009-09

Outcome

Outcome not reported

Stopped (Enrollment): “Inability to enroll subjects.”

Drugs

Indications